XBI
$133.66SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense ratio
0.35%
Dividend yield
0.34%
AUM
$8.30B
Issuer
State Street
YTD return
12.92%
1Y return
—
5Y return
—
10Y return
—
Top holdings
Top holdings · XBI
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
Sector exposure
Sector breakdown · XBI
Financial Services0.2%
Healthcare99.8%